BNCM: DELEX CORPORATE ACTIONS & EXPANSION PLANS FOR

New Post Public Reply Private Reply Replies (0) Message Board
wayno2
83
BNCM: DELEX CORPORATE ACTIONS & EXPANSION PLANS FOR 2026
Press Release
OTC Disclosure & News Service | 02/09/2026
February 2026 — BNCM today provided an update on its ongoing corporate actions and the growth outlook of Delex Healthcare Group, Inc. (DELEX), a profitable pharmaceutical and healthcare company with a strong presence in the Philippines.

Name and Ticker Symbol Change

BNCM has submitted applications for its corporate name change to Delex Healthcare Group and ticker symbol change to DELEX with the U.S. Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA), respectively. Shareholders will be informed upon receipt of regulatory approvals.

Company Background

Founded in 2009, Delex Pharma International, Inc. has over 15 years of experience developing and distributing affordable, high-quality critical care medications. The company has established one of the most extensive pharmaceutical distribution networks in the Philippines, serving hospitals, pharmacies, and healthcare professionals nationwide.

Management and Market Position

DELEX is led by a seasoned management team with decades of combined experience across local and multinational pharmaceutical companies. Their expertise spans sales, marketing, operations, regulatory affairs, information technology, and human resources.

According to the IQVIA MAT Report, DELEX ranked as the third-largest national pharmaceutical company in the hospital channel in the Philippines as of December 2020.

Current Operations

DELEX currently employs approximately 200 staff, maintains over 30 FDA-approved hospital products, and supplies more than 900 pharmacies and hospitals, 160 drug chains, and 380 dispensing physicians and clinics. The company also operates three pharmacy retail locations.

Key Strengths and Expansion Plans

1. Sustained Growth: Fifteen years of consistent business growth supported by strong leadership, in-demand products, and established regional partnerships.



2. Regulatory Strength: Holder of multiple Philippine FDA licenses covering pharmaceutical importation, distribution, medical devices, cosmetics, food products, and retail drugstores, including online delivery operations.



3. Product Expansion: Portfolio includes over 30 FDA-approved hospital products, with 11 new pharmaceutical launches and expanding medical device offerings.



4. Medical Devices: Strategic alliances with global manufacturers such as Amsino, Masimo, and Verathon to grow its medical device segment.



5. Retail Pharmacy Growth: Plans to expand pharmacy locations to up to 60 stores, strategically located near hospitals and high-traffic areas.


6. ePharmacy Platform: Continued expansion of its 24/7 online pharmacy and delivery services to meet rising digital healthcare demand.



7. Global Engagement: The DELEX ICU Forum, now a global online educational platform, has reached nearly 200,000 healthcare professionals worldwide.



8. Infrastructure & Logistics: Ongoing investments in warehouse expansion, trade sales teams, and SAP ERP systems to enhance operational efficiency.



9. Strategic Acquisition: Acquisition of JMN Brothers Pharma Limited to expand into women’s health and beauty product segments.



10. Quality Assurance: ISO 9001:2015 re-certification, demonstrating commitment to international quality standards.



11. Industry Recognition: Multiple awards, including CEO of the Year 2025, Best Employer Brand Award 2025, and SME Company of the Year.


Market Opportunity

Asia’s pharmaceutical market exceeds US$600 billion, while the medical device market surpasses US$110 billion, driven by population growth, rising healthcare demand, and technological adoption. DELEX is strategically positioned to capture growth through product development, partnerships, and regional expansion.

About DELEX Healthcare Group, Inc. (DELEX)


DELEX is on a mission to revolutionize the pharmaceutical and healthcare industry. As a Delaware-registered company, DELEX partners with JMN Brothers Pharma Limited, Inc. and DLX Holdings, Inc., bringing high-quality products to market. With a focus on innovation, regulatory excellence, and customer service, DELEX strives to meet the growing demands of the market while adhering to the highest standards of regulatory compliance and customer service excellence.


For more information, visit www.delexpharma.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 113

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 121

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading

Top 5 Most Recently Viewed Articles

Beta Glucan Market Set to Exceed USD 31 Billion by 2030

Updated Category News Views 56

Exploring the Growth of the Beta Glucan Market The beta glucan market is experiencing remarkable growth, largely driven by increasing awareness of its health benefits. More and more consumers are recognizing the importance of supporting their immune systems and managing cholesterol levels, which has led to a surge in demand across numerous sectors, including...

Continue Reading
AiPPT.com: Crafting the Next Era of AI-Driven Presentations

Updated Category News Views 177

Transforming Presentations with AiPPT.com In the evolving landscape of digital work, AiPPT.com stands out as a leading provider of AI-native tools that are reshaping the way presentations are crafted. As an advanced AI presentation maker, AiPPT.com is committed to enhancing user experiences by making the process of creating engaging and professional presentations much...

Continue Reading
Acme Mills Launches Natura: Revolutionizing Sustainable Fabrics

Updated Category News Views 244

Revolutionizing Textile Innovation with Natura Acme Mills Company, a recognized pioneer in textile manufacturing, has proudly unveiled its latest innovation, Natura. This new line of bio-based polylactic acid (PLA) fabrics aims to replace traditional petroleum-based materials such as PET, PP, and Nylon. With Natura, Acme Mills is not just promoting a product; it is...

Continue Reading
Class Action Alert for C3.ai, Inc. Investors - Join Now!

Updated Category News Views 123

Opportunity for C3.ai, Inc. Shareholders to Join Class Action Attention, shareholders of C3.ai, Inc. (NYSE: AI). A significant class action suit is currently underway, and your involvement could be crucial. If you purchased shares during the class period, there may be an opportunity for you to participate in a recovery process without the requirement of being a lead...

Continue Reading
EyePoint Pharmaceuticals: Innovations and Financial Insights

Updated Category News Views 224

EyePoint Pharmaceuticals Set to Showcase Q2 Financials EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pioneering company dedicated to developing advanced therapeutics for serious retinal diseases, plans to share its second quarter 2025 financial results. This announcement will be accompanied by a live conference call and webcast on a scheduled day, promising to provide...

Continue Reading